Patent · US Active

Hydrophobic modified peptides and their use for liver specific targeting

US10513539B2 · kind B2 · utility

0Cited by

0References

38Claims

0Family size

Assignee

RUPRECHT - KARLS - UNIVERSITÄT HEIDELBERG · DE

Inventors

Walter Mier · Bensheim, DE
Stephan Urban · Neustadt, DE
Stefan Mehrle · Schifferstadt, DE
Uwe Haberkorn · Schwetzingen, DE

Key dates

Filing date	Feb 10, 2012
Grant date	Dec 24, 2019
Priority date	—
Expiry date	Mar 14, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to hydrophobic modified peptides for the specific delivery of compounds to the liver, preferably to hepatocytes, in vitro as well as in vivo. The present invention relates to pharmaceutical compositions comprising said hydrophobic modified peptide(s) and the compound(s) to be specifically delivered to the liver. The present invention furthermore relates to the use of the inventive hydrophobic modified peptides as well as to a method for the prevention and/or treatment of liver diseases or disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.